A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.

Using specimens from a population-based case control study among women ages 18 to 44 years in western Washington, we assessed the relationship between carriership of a genetic clotting factor II variant (20210 G-->A) and myocardial infarction (MI). The factor II variant was previously shown to be present in 1% to 2% of the population, to increase the levels of factor II, and to be associated with venous thrombotic disease. Personal interviews and blood samples were obtained from 79 women with a first myocardial infarction and 381 control women identified through random-digit telephone dialing. Polymerase chain reaction (PCR) method was used to determine the factor II genotypes. The factor II 20210 G to A transition was present more often in women with MI (5.1%) than among control women (1.6%). The age-adjusted odds ratio for MI was 4.0 (95% confidence interval 1.1 to 15.1). The relative risk was high when another major cardiovascular risk factor was also present, such as smoking (odds ratio 43.3, 95% confidence interval 6.7 to 281), and the risk seemed limited to those with other risk factors. These results, in which the effect of major coronary risk factors is enhanced fourfold to sixfold by the prothrombin variant, are similar to those previously reported for another genetic clotting abnormality, factor V Leiden. We conclude that factor II 20210 G to A increases the risk of myocardial infarction in young women, especially in the women with other major risk factors for coronary heart disease.

[1]  R. Bertina,et al.  Thrombin, a Link between Coagulation Activation and Fibrinolysis a , 1992, Annals of the New York Academy of Sciences.

[2]  F. Rosendaal,et al.  Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[3]  T. Raghunathan,et al.  Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. , 1997, Blood.

[4]  E. Davie,et al.  Nucleotide sequence of the gene for human prothrombin. , 1987, Biochemistry.

[5]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[6]  T. Raghunathan,et al.  Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. , 1997, Circulation.

[7]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[8]  L. Fisher,et al.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). , 1995, Journal of the American College of Cardiology.

[9]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[10]  J. Clegg,et al.  Evidence for a single origin of factor V Leiden , 1996, British journal of haematology.

[11]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Petitti,et al.  Myocardial Infarction in Users of Low‐Dose Oral Contraceptives , 1996, Obstetrics and gynecology.

[13]  P. W. Farrell,et al.  Myocardial infarction in young adults: risk factors and natural history. , 1983, American heart journal.

[14]  W. Mckenna,et al.  Myocardial infarction with normal coronary angiogram. Possible mechanism of smoking risk in coronary artery disease. , 1980, British heart journal.

[15]  J. Clegg,et al.  World distribution of factor V Leiden , 1995, The Lancet.

[16]  J. Jones,et al.  Myocardial infarction in young adults: risk factors and clinical features. , 1996, The Journal of emergency medicine.

[17]  S. Glišić,et al.  A simple PCR method for detection of defined point mutations. , 1996, Trends in genetics : TIG.

[18]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[19]  R. Bergstrand,et al.  Myocardial infarction among men below age 40. , 1978, British heart journal.

[20]  P. Hartge,et al.  Random digit dialing in selecting a population-based control group. , 1984, American journal of epidemiology.

[21]  B. Psaty,et al.  Thrombosis in the Young: Effect of Atherosclerotic Risk Factors on the Risk of Myocardial Infarction Associated with Prothrombotic Factors , 1997, Thrombosis and Haemostasis.